High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli

Recombinant expression systems have become powerful tools for understanding the structure and function of proteins, including the apolipoproteins that comprise human HDL. However, human apolipoprotein (apo)A-II has proven difficult to produce by recombinant techniques, likely contributing to our lac...

Full description

Bibliographic Details
Main Authors: Loren E. Smith, Jun Yang, Leah Goodman, Xinqi Huang, Rong Huang, James Dressman, Jamie Morris, R. A. Gangani D. Silva, W. Sean Davidson, Giorgio Cavigiolio
Format: Article
Language:English
Published: Elsevier 2012-08-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520418759
id doaj-93d182fbdc2a450cb9cc608277ac48e8
record_format Article
spelling doaj-93d182fbdc2a450cb9cc608277ac48e82021-04-28T06:05:33ZengElsevierJournal of Lipid Research0022-22752012-08-0153817081715High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coliLoren E. Smith0Jun Yang1Leah Goodman2Xinqi Huang3Rong Huang4James Dressman5Jamie Morris6R. A. Gangani D. Silva7W. Sean Davidson8Giorgio Cavigiolio9Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andthe Children's Hospital Oakland Research Institute, Oakland, CA 94609the Children's Hospital Oakland Research Institute, Oakland, CA 94609Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andTo whom correspondence should be addressed. e-mail: gcavigiolio@chori.org; parafilm@tiscali.it; or davidswm@ucmail.uc.edu.; Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45273 andTo whom correspondence should be addressed. e-mail: gcavigiolio@chori.org; parafilm@tiscali.it; or davidswm@ucmail.uc.edu.; the Children's Hospital Oakland Research Institute, Oakland, CA 94609Recombinant expression systems have become powerful tools for understanding the structure and function of proteins, including the apolipoproteins that comprise human HDL. However, human apolipoprotein (apo)A-II has proven difficult to produce by recombinant techniques, likely contributing to our lack of knowledge about its structure, specific biological function, and role in cardiovascular disease. Here we present a novel Escherichia coli-based recombinant expression system that produces highly pure mature human apoA-II at substantial yields. A Mxe GyrA intein containing a chitin binding domain was fused at the C terminus of apoA-II. A 6× histidine-tag was also added at the fusion protein's C terminus. After rapid purification on a chitin column, intein auto-cleavage was induced under reducing conditions, releasing a peptide with only one extra N-terminal Met compared with the sequence of human mature apoA-II. A pass through a nickel chelating column removed any histidine-tagged residual fusion protein, leaving highly pure apoA-II. A variety of electrophoretic, mass spectrometric, and spectrophotometric analyses demonstrated that the recombinant form is comparable in structure to human plasma apoA-II. Similarly, recombinant apoA-II is comparable to the plasma form in its ability to bind and reorganize lipid and promote cholesterol efflux from macrophages via the ATP binding cassette transporter A1. This system is ideal for producing large quantities of recombinant wild-type or mutant apoA-II for structural or functional studies.http://www.sciencedirect.com/science/article/pii/S0022227520418759inteinfusion proteinaffinity tagbacteriainexpensivelow temperature cleavage
collection DOAJ
language English
format Article
sources DOAJ
author Loren E. Smith
Jun Yang
Leah Goodman
Xinqi Huang
Rong Huang
James Dressman
Jamie Morris
R. A. Gangani D. Silva
W. Sean Davidson
Giorgio Cavigiolio
spellingShingle Loren E. Smith
Jun Yang
Leah Goodman
Xinqi Huang
Rong Huang
James Dressman
Jamie Morris
R. A. Gangani D. Silva
W. Sean Davidson
Giorgio Cavigiolio
High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli
Journal of Lipid Research
intein
fusion protein
affinity tag
bacteria
inexpensive
low temperature cleavage
author_facet Loren E. Smith
Jun Yang
Leah Goodman
Xinqi Huang
Rong Huang
James Dressman
Jamie Morris
R. A. Gangani D. Silva
W. Sean Davidson
Giorgio Cavigiolio
author_sort Loren E. Smith
title High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli
title_short High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli
title_full High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli
title_fullStr High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli
title_full_unstemmed High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli
title_sort high yield expression and purification of recombinant human apolipoprotein a-ii in escherichia coli
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2012-08-01
description Recombinant expression systems have become powerful tools for understanding the structure and function of proteins, including the apolipoproteins that comprise human HDL. However, human apolipoprotein (apo)A-II has proven difficult to produce by recombinant techniques, likely contributing to our lack of knowledge about its structure, specific biological function, and role in cardiovascular disease. Here we present a novel Escherichia coli-based recombinant expression system that produces highly pure mature human apoA-II at substantial yields. A Mxe GyrA intein containing a chitin binding domain was fused at the C terminus of apoA-II. A 6× histidine-tag was also added at the fusion protein's C terminus. After rapid purification on a chitin column, intein auto-cleavage was induced under reducing conditions, releasing a peptide with only one extra N-terminal Met compared with the sequence of human mature apoA-II. A pass through a nickel chelating column removed any histidine-tagged residual fusion protein, leaving highly pure apoA-II. A variety of electrophoretic, mass spectrometric, and spectrophotometric analyses demonstrated that the recombinant form is comparable in structure to human plasma apoA-II. Similarly, recombinant apoA-II is comparable to the plasma form in its ability to bind and reorganize lipid and promote cholesterol efflux from macrophages via the ATP binding cassette transporter A1. This system is ideal for producing large quantities of recombinant wild-type or mutant apoA-II for structural or functional studies.
topic intein
fusion protein
affinity tag
bacteria
inexpensive
low temperature cleavage
url http://www.sciencedirect.com/science/article/pii/S0022227520418759
work_keys_str_mv AT lorenesmith highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT junyang highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT leahgoodman highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT xinqihuang highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT ronghuang highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT jamesdressman highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT jamiemorris highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT raganganidsilva highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT wseandavidson highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
AT giorgiocavigiolio highyieldexpressionandpurificationofrecombinanthumanapolipoproteinaiiinescherichiacoli
_version_ 1721504213174845440